Robert Driscoll - Profile and Investment Details

Investor Profile

Robert Driscoll is a Venture Capital, Private Equity Firm, Micro VC, Investment Partner based in Radnor, Pennsylvania, United States with a diverse investment portfolio that includes companies such as BioDetego, Hsiri Therapeutics, Mebias Discovery, Noble.MD, Treventis, CarePartners Plus, Solaris Therapeutics, Relmada Therapeutics, RMH Sciences, Group K Diagnostics, Melior Discovery, Imiplex, Penn-Greene, Genome Profiling, ENB Therapeutics, InfraScan, Enzium, Bainbridge Health, Cohero HealthCytovas, Anakim, Allevi, Keriton, Cool-Bio, Wellsheet, Galleon Pharmaceuticals, Oncora Medical, Niiki Pharma, TowerView Health, Annovis Bio, Palvella Therapeutics, Ride Health, Merganser Biotech, Pillo Health, Renovacor, Life Mist Technologies, Novira Therapeutics, TalexMedical, Jenrin Discovery, Olive Devices, Venatorx Pharmaceuticals, Microbiota, Innovative Supply Solutions, RiboNova Inc., WellTrackONE, Penn State Hershey Medical Center, OSSIANIX, Halo Labs, Immunome, HealthQx, Ceptaris Therapeutics, . Over time, Robert Driscoll has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Robert Driscoll is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Hospitals, Wellness, Women Founded, Fundraising, Transportation, Healthcare Innovation, Strategic Partnerships, Life Science, Engineering, Health Technology, Portfolio Management, Medical Technologies, Robotics, Analytics, Venture Fundraising, 3D Technology, Software, Biotechnology, Medical Devices, Innovation, Clinical Trials, Disruptive technology, Home Care, Hardware, Mergers and Acquisitions, Health Diagnostics, Digital Health, Medical, SaaS, Information Technology, B2B, Therapeutics, Health Tech, Machine Learning, Pharmaceuticals, Healthcare Technology, Acquisitions may find it worthwhile to explore potential connections with Robert Driscoll, as their portfolio suggests a familiarity and interest in this area.

Understanding Robert Driscoll’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.